APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.47
+0.06 (+0.71%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close 8.41
Open 8.40
Bid 7.44 x 1100
Ask 8.50 x 900
Day's Range 8.39 - 8.51
52 Week Range 6.10 - 8.89
Volume 91,897
Avg. Volume 159,112
Market Cap 281.234M
Beta (3Y Monthly) 0.40
PE Ratio (TTM) 4.27
EPS (TTM) 1.98
Earnings Date Mar 13, 2019
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 10.75
Trade prices are not sourced from all markets
  • Business Wire 13 days ago

    Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced that financial results for the fourth quarter and fiscal year 2018 will be released after the market closes on Wednesday, March 13. To listen to the call by phone, interested parties may dial 844-507-6493 (or 647-253-8641 for international callers) and provide access code 5488443. Participants should ask for the Apyx Medical Corporation Call.

  • Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%
    Zacks 16 days ago

    Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%

    Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

  • Has Bovie Medical (APYX) Outpaced Other Medical Stocks This Year?
    Zacks 26 days ago

    Has Bovie Medical (APYX) Outpaced Other Medical Stocks This Year?

    Is (APYX) Outperforming Other Medical Stocks This Year?

  • Bovie Medical (APYX) is a Great Momentum Stock: Should You Buy?
    Zacks last month

    Bovie Medical (APYX) is a Great Momentum Stock: Should You Buy?

    Does Bovie Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.

  • Business Wire last month

    Apyx Medical Corporation Announces the Promotion of Todd Hornsby to Executive Vice President

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced that Todd Hornsby has been promoted to Executive Vice President, effective January 2, 2019. Mr. Hornsby joined Apyx Medical in August, 2014, and held the position of Vice President and General Manager of Advanced Energy prior to his promotion. “Todd has done an excellent job leading the global sales and marketing efforts for our Advanced Energy business, specifically the commercialization of our Renuvion Cosmetic Technology in the U.S. cosmetic surgery market and in an increasing number of international markets as well,” said Charlie Goodwin, President and Chief Executive Officer.

  • Business Wire last month

    Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2018.